Novocure Total Liab vs Capital Surpluse Analysis

NVCR Stock

USD 17.73 0.64 3.74%

Novocure financial indicator trend analysis is infinitely more than just investigating Novocure recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Novocure is a good investment. Please check the relationship between Novocure Total Liab and its Capital Surpluse accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novocure. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

To learn how to invest in Novocure Stock, please use our How to Invest in Novocure guide.

Total Liab vs Capital Surpluse

Total Liab vs Capital Surpluse Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Novocure Total Liab account and Capital Surpluse. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Novocure's Total Liab and Capital Surpluse is 0.93. Overlapping area represents the amount of variation of Total Liab that can explain the historical movement of Capital Surpluse in the same time period over historical financial statements of Novocure, assuming nothing else is changed. The correlation between historical values of Novocure's Total Liab and Capital Surpluse is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Liab of Novocure are associated (or correlated) with its Capital Surpluse. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capital Surpluse has no effect on the direction of Total Liab i.e., Novocure's Total Liab and Capital Surpluse go up and down completely randomly.

Correlation Coefficient

0.93

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Total Liab

The total amount of all liabilities that a company has, including both short-term and long-term liabilities.

Capital Surpluse

Most indicators from Novocure's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Novocure current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novocure. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

To learn how to invest in Novocure Stock, please use our How to Invest in Novocure guide.As of 11/22/2024, Selling General Administrative is likely to drop to about 87.6 M. In addition to that, Tax Provision is likely to drop to about 9.1 M

	2021	2022	2023	2024 (projected)
Interest Expense	3.4M	3.3M	4.1M	7.7M
Depreciation And Amortization	10.3M	10.6M	11.0M	7.8M

Interest Expense Depreciation And Amortization

Novocure fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross
Total Assets		0.97	0.1	0.89	0.93	0.65	0.95	0.8	0.91	-0.77	0.88	0.51	0.82	0.91	0.93	0.93	1.0	0.88	0.71	0.99	0.93	0.78	0.58	0.94	0.92	0.64
Short Long Term Debt Total	0.97		0.1	0.89	0.84	0.63	0.86	0.8	0.94	-0.82	0.88	0.38	0.82	0.9	0.91	0.93	0.96	0.88	0.77	0.97	0.93	0.84	0.51	0.95	0.92	0.66
Other Current Liab	0.1	0.1		0.37	0.02	0.28	0.14	0.48	0.23	-0.49	0.35	0.22	0.47	0.38	0.34	0.3	0.08	-0.04	0.22	0.04	0.3	0.38	0.77	0.27	0.32	0.66
Total Current Liabilities	0.89	0.89	0.37		0.76	0.63	0.79	0.97	0.96	-0.93	0.99	0.41	0.98	0.99	0.98	0.98	0.87	0.82	0.73	0.87	0.98	0.81	0.67	0.91	0.99	0.89
Total Stockholder Equity	0.93	0.84	0.02	0.76		0.58	0.97	0.68	0.78	-0.57	0.77	0.58	0.7	0.82	0.84	0.82	0.95	0.79	0.52	0.92	0.82	0.59	0.59	0.81	0.81	0.5
Other Liab	0.65	0.63	0.28	0.63	0.58		0.54	0.49	0.59	-0.7	0.55	0.4	0.51	0.65	0.67	0.63	0.61	0.8	0.66	0.59	0.64	0.75	0.57	0.75	0.64	0.4
Net Tangible Assets	0.95	0.86	0.14	0.79	0.97	0.54		0.74	0.78	-0.63	0.8	0.64	0.76	0.84	0.85	0.83	0.96	0.73	0.54	0.92	0.83	0.65	0.63	0.85	0.83	0.59
Property Plant And Equipment Net	0.8	0.8	0.48	0.97	0.68	0.49	0.74		0.91	-0.9	0.98	0.39	1.0	0.95	0.94	0.93	0.79	0.67	0.64	0.78	0.94	0.75	0.69	0.84	0.95	0.96
Net Debt	0.91	0.94	0.23	0.96	0.78	0.59	0.78	0.91		-0.89	0.95	0.25	0.92	0.95	0.96	0.98	0.9	0.83	0.72	0.93	0.98	0.81	0.59	0.91	0.98	0.79
Retained Earnings	-0.77	-0.82	-0.49	-0.93	-0.57	-0.7	-0.63	-0.9	-0.89		-0.89	-0.24	-0.91	-0.88	-0.88	-0.88	-0.73	-0.77	-0.71	-0.75	-0.88	-0.93	-0.62	-0.92	-0.89	-0.88
Accounts Payable	0.88	0.88	0.35	0.99	0.77	0.55	0.8	0.98	0.95	-0.89		0.42	0.99	0.98	0.98	0.98	0.87	0.77	0.68	0.87	0.98	0.76	0.66	0.88	0.99	0.9
Cash	0.51	0.38	0.22	0.41	0.58	0.4	0.64	0.39	0.25	-0.24	0.42		0.41	0.5	0.49	0.43	0.52	0.36	0.39	0.39	0.44	0.22	0.5	0.4	0.44	0.32
Non Current Assets Total	0.82	0.82	0.47	0.98	0.7	0.51	0.76	1.0	0.92	-0.91	0.99	0.41		0.97	0.95	0.95	0.81	0.69	0.66	0.8	0.95	0.76	0.7	0.86	0.96	0.95
Non Currrent Assets Other	0.91	0.9	0.38	0.99	0.82	0.65	0.84	0.95	0.95	-0.88	0.98	0.5	0.97		1.0	0.99	0.9	0.81	0.73	0.89	0.99	0.77	0.73	0.9	0.99	0.86
Other Assets	0.93	0.91	0.34	0.98	0.84	0.67	0.85	0.94	0.96	-0.88	0.98	0.49	0.95	1.0		0.99	0.92	0.84	0.75	0.9	0.99	0.78	0.71	0.91	0.99	0.83
Long Term Debt	0.93	0.93	0.3	0.98	0.82	0.63	0.83	0.93	0.98	-0.88	0.98	0.43	0.95	0.99	0.99		0.92	0.83	0.74	0.92	1.0	0.78	0.66	0.91	1.0	0.83
Cash And Short Term Investments	1.0	0.96	0.08	0.87	0.95	0.61	0.96	0.79	0.9	-0.73	0.87	0.52	0.81	0.9	0.92	0.92		0.85	0.68	0.99	0.92	0.74	0.57	0.92	0.91	0.62
Net Receivables	0.88	0.88	-0.04	0.82	0.79	0.8	0.73	0.67	0.83	-0.77	0.77	0.36	0.69	0.81	0.84	0.83	0.85		0.78	0.86	0.83	0.77	0.41	0.88	0.83	0.48
Common Stock Shares Outstanding	0.71	0.77	0.22	0.73	0.52	0.66	0.54	0.64	0.72	-0.71	0.68	0.39	0.66	0.73	0.75	0.74	0.68	0.78		0.66	0.74	0.69	0.53	0.72	0.74	0.5
Short Term Investments	0.99	0.97	0.04	0.87	0.92	0.59	0.92	0.78	0.93	-0.75	0.87	0.39	0.8	0.89	0.9	0.92	0.99	0.86	0.66		0.92	0.76	0.53	0.92	0.91	0.62
Non Current Liabilities Total	0.93	0.93	0.3	0.98	0.82	0.64	0.83	0.94	0.98	-0.88	0.98	0.44	0.95	0.99	0.99	1.0	0.92	0.83	0.74	0.92		0.79	0.67	0.91	1.0	0.83
Inventory	0.78	0.84	0.38	0.81	0.59	0.75	0.65	0.75	0.81	-0.93	0.76	0.22	0.76	0.77	0.78	0.78	0.74	0.77	0.69	0.76	0.79		0.55	0.93	0.79	0.72
Other Current Assets	0.58	0.51	0.77	0.67	0.59	0.57	0.63	0.69	0.59	-0.62	0.66	0.5	0.7	0.73	0.71	0.66	0.57	0.41	0.53	0.53	0.67	0.55		0.61	0.67	0.7
Other Stockholder Equity	0.94	0.95	0.27	0.91	0.81	0.75	0.85	0.84	0.91	-0.92	0.88	0.4	0.86	0.9	0.91	0.91	0.92	0.88	0.72	0.92	0.91	0.93	0.61		0.92	0.74
Total Liab	0.92	0.92	0.32	0.99	0.81	0.64	0.83	0.95	0.98	-0.89	0.99	0.44	0.96	0.99	0.99	1.0	0.91	0.83	0.74	0.91	1.0	0.79	0.67	0.92		0.84
Property Plant And Equipment Gross	0.64	0.66	0.66	0.89	0.5	0.4	0.59	0.96	0.79	-0.88	0.9	0.32	0.95	0.86	0.83	0.83	0.62	0.48	0.5	0.62	0.83	0.72	0.7	0.74	0.84

Click cells to compare fundamentals

Novocure Account Relationship Matchups

Novocure fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	479.4M	1.1B	1.1B	1.2B	1.1B	651.0M
Short Long Term Debt Total	187.1M	444.2M	632.2M	639.1M	596.2M	305.9M
Other Current Liab	(1K)	36.9M	(17.8M)	(18.0M)	59.4M	62.3M
Total Current Liabilities	86.3M	113.6M	142.6M	158.8M	179.1M	188.1M
Total Stockholder Equity	217.8M	476.5M	410.5M	441.2M	362.5M	279.7M
Other Liab	11.7M	17.6M	11.2M	7.4M	8.5M	8.8M
Net Tangible Assets	217.8M	476.5M	410.5M	441.2M	507.3M	267.8M
Property Plant And Equipment Net	34.6M	41.6M	53.9M	69.0M	97.7M	102.6M
Net Debt	(13.8M)	209.5M	366.4M	468.9M	355.4M	373.2M
Retained Earnings	(650.9M)	(631.1M)	(685.9M)	(778.5M)	(985.5M)	(936.2M)
Accounts Payable	36.9M	53.6M	72.6M	85.2M	94.4M	99.1M
Cash	177.3M	234.7M	208.8M	115.3M	240.8M	164.9M
Non Current Assets Total	39.5M	52.5M	66.0M	80.1M	111.7M	117.3M
Non Currrent Assets Other	4.9M	10.9M	12.1M	11.2M	14.0M	14.7M
Other Assets	4.9M	10.9M	12.1M	11.2M	12.8M	13.5M
Long Term Debt	149.4M	429.9M	562.2M	565.5M	568.8M	597.3M
Cash And Short Term Investments	326.1M	842.6M	937.7M	969.4M	910.6M	518.3M
Net Receivables	88.1M	96.7M	110.6M	112.2M	61.2M	59.3M
Common Stock Shares Outstanding	97.2M	108.9M	103.4M	104.7M	106.4M	96.1M
Short Term Investments	148.8M	607.9M	728.9M	854.1M	669.8M	353.5M
Liabilities And Stockholders Equity	479.4M	1.1B	1.1B	1.2B	1.1B	651.0M
Non Current Liabilities Total	175.3M	461.8M	586.4M	591.7M	604.5M	634.7M
Inventory	23.7M	27.4M	24.4M	29.4M	38.2M	23.2M
Other Current Assets	1K	32.7M	807K	6.7M	24.4M	25.6M
Other Stockholder Equity	871.4M	1.1B	1.1B	1.2B	1.4B	916.6M
Total Liab	261.7M	575.5M	729.0M	750.5M	783.6M	822.8M
Total Current Assets	439.9M	999.4M	1.1B	1.1B	1.0B	607.6M
Accumulated Other Comprehensive Income	(2.8M)	(3.8M)	(3.2M)	(2.4M)	(5.5M)	(5.2M)
Property Plant Equipment	34.6M	11.4M	53.9M	32.7M	37.6M	22.9M
Retained Earnings Total Equity	(650.9M)	(631.1M)	(685.9M)	(778.5M)	(700.6M)	(735.6M)
Current Deferred Revenue	11.8M	17.8M	17.8M	18.0M	16.2M	13.4M
Long Term Debt Total	149.5M	429.9M	562.2M	565.5M	650.3M	682.9M
Capital Surpluse	871.4M	1.1B	1.1B	1.2B	1.4B	1.0B
Non Current Liabilities Other	182K	31.9M	166K	148K	18K	17.1K
Net Invested Capital	367.2M	906.4M	972.7M	1.0B	931.3M	731.9M
Net Working Capital	353.6M	885.8M	930.9M	952.8M	855.3M	696.2M

Additional Tools for Novocure Stock Analysis

When running Novocure's price analysis, check to measure Novocure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novocure is operating at the current time. Most of Novocure's value examination focuses on studying past and present price action to predict the probability of Novocure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novocure's price. Additionally, you may evaluate how the addition of Novocure to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Novocure Total Liab vs Capital Surpluse Analysis

Total Liab vs Capital Surpluse

Total Liab vs Capital Surpluse Correlation Analysis

Correlation Coefficient

Total Liab

Capital Surpluse

Novocure fundamental ratios Correlations

Novocure Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Novocure fundamental ratios Accounts

Additional Tools for Novocure Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Total Assets
Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Other Assets	+ 1.0	Non Currrent Assets Other
Non Current Liabilities Total	+ 1.0	Long Term Debt
Total Liab	+ 1.0	Long Term Debt
Total Liab	+ 1.0	Non Current Liabilities Total

Inventory	- 0.93	Retained Earnings
Retained Earnings	- 0.93	Total Current Liabilities
Other Stockholder Equity	- 0.92	Retained Earnings
Non Current Assets Total	- 0.91	Retained Earnings
Retained Earnings	- 0.9	Property Plant And Equipment Net
Total Liab	- 0.89	Retained Earnings